ADPT — Adaptogenics Health Balance Sheet
0.000.00%
- CA$0.41m
- CA$0.34m
- CA$0.00m
Annual balance sheet for Adaptogenics Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.534 | 0.262 | 0.149 | 0.08 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.004 | 0.004 | 0.005 | 0.003 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.578 | 0.303 | 0.154 | 0.084 |
| Total Assets | 0.578 | 0.303 | 0.154 | 0.084 |
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.048 | 0.039 | 0.022 | 0.027 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.048 | 0.039 | 0.022 | 0.027 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 0.529 | 0.264 | 0.132 | 0.058 |
| Total Liabilities & Shareholders' Equity | 0.578 | 0.303 | 0.154 | 0.084 |
| Total Common Shares Outstanding |